Патогенетический Анализ Взаимосвязи Между Helicobacter Pylori И Артериальной Гипертензией
Keywords:
артериальная гипертензия, Helicobacter pylori
Abstract
литературы анализирует исследования последних лет, посвященные изучению роли Helicobacter pylori в развитии AГ, используя данные из научной литературы, данные, направленные на решение взаимопатогенетических отношений между двумя проблемами, имеют важное значение. Результатом нескольких проверок является H. люди с пилори имеют более высокий риск развития артериальной гипертензии, чем люди без нее. H.пилори было обнаружено, что являются патологическими механизмами. H. в основе взаимной патогенетической зависимости в развитии пилори и АГ лежат данные о возникновении эндотелиальной дисфункции, которая сопровождается повышением количества воспалительных цитокинов, гомоцистеинемией, снижением витамина D.
References
1. Wan Z., Hu L . Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults // Journal of Human Hypertension - 2022.32(2). -P 158–164.
2. Huang M., Zhu L., Yao Y. 2021. Association between Helicobacter pylori infection and systemic arterial hypertension: a meta-analysis // Journal Arquivos Brasileiros de Cardiologia 2021.117(2). -P 626–636.
3. Kowalski M. 2001. Helicobacter pylori (H. pylori) infection in coronary artery disease: inflfluence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specifific DNA in human coronary atherosclerotic plaque. //Journal of Physiology and Pharmacology -2001.52. -P 3–31.
4. Agita A., Alsagaff MT. Inflammation, Immunity, and Hypertension. // Acta medica Indonesiana - 2017.49 (2). -P 158–165.
5. Jeong HY., Park KM., Lee MJ., Yang DH., Lee SY. Vitamin D and Hypertension. // Electrolyte & blood pressure: E& BP-2017. 15(1)- P1–11.
6. Shafrir A., Shauly-Aharonov M., Katz LH., Ackerman Z. The Association between Serum Vitamin D Levels and Helicobacter pylori. // Presence and Eradication- 2021.13(1)-P 13-28.
7. Tousoulis D., Davies GJ., Asimakopoulos G., Homaei H, Zouridakis., Kaski JC. Vascular cell adhesion molecule-1 and inter cellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). // Clinical Cardiology- 2001. 24.-P 301-304
8. Patel., Ali M.K., Cardiovascular mortality associated with 5 leading risk factors: National and state preventable fractions estimated from survey data. // Annals of Internal Medicine - 2015. 163.-P 245–253.
9. Dore., Pes G.M. The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease. // Journal of Atherosclerosi and Thrombosis.- 2021. 28.-P 604–610.
10. Szwed P., Gasecka A.,Filipiak, K.J. Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications. // Journal of Clinical and Medicine.-2021. 10.-P 25-39.
11. Kalisperati P., Spanou E., Pateras IS., et al. Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis. // Frontiers in genetics.- 2017. 8.-P 20.
12. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood coagulation & fibrinolysi. // An international journal in haemostasis and thrombosis. -1999. 10.1.-P 9–12.
13. Kowalski M., Pawlik M., Konturek JW., Konturek SJ. Helicobacter infection in coronary artery disease. // Journal of Physiology and Pharmacology.- 2006.3. -P 101–11.
14. Lee SY., Kim DK., Son HJ., Lee JH., Kim YH., Kim JJ., et al. The impact of Helicobacter pylori infection on coronary heart disease in Korean Population. // Korean Journal of Gastroenterology. 2004.44. -P 193–823.
15. Franceschi F., Niccoli G., Ferrente G., Gasbarrini A., Baldi A., Candelli M, et al., Cag A. antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and meta-analysis of 4241 cases. // Atherosclerosis. 2009.202.-P 535–42.
16. Migneco A., Ojetti V., Specchia L., Franceschi F., Candelli M., Mettimano M, et al. Eradication of Helico bacter pylori infection improves blood pressure values in patients affected by hypertension. // Helicobacter. 2003. 8(6).-P 585–589.
17. Yamaoka Y., Kita M, Kodama T., Sawai N., Imanishi J. Helicobacter pylori CagA gene and expression of cytokine messenger RNA in gastric mucosa. // Gastroenterology. 1996. 110(6).-P 1744–1752.
18. Longo-Mbenza B., Nsenga JN., Mokondjimobe E., Gombet T., Assori IN., Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. // Vascular health and risk management. 2012. 6: -P 455–461.
19. Ping Yang ., Wei Shi. Helicobacter pylori and hypertension: a cross-sectional study based on a healthy population. // Research Square Platform LLC. 10.21203.
20. Franceschi F., Annalisa T., Teresa DR., Giovanna D., Ianiro G., Franco S, et al. Role of Helicobacter pylori infection on nutrition and metabolism. // World journal of gastroenterology: WJG. 2014. 20(36): -P 12809 – 12817.
21. Xiong XL, Chen J, He MA, Wu TC, Yang HD. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: The Dongfeng-Tongji cohort. Journal of Clinical Hypertension. 2020; 22(8).-P 234-300.
22. Liuba P., Pesonen E., Paakkari I., Batra S., Andersen L., Forslid A., et al. Co-infection with Chlamydia pneumoniae and Helicobacter pyloriresults in vascular endothelial dysfunction and enhanced VCAM-1 expression in ApoE-knockout mice. J Vasc Res. (2003) 40:115–
23. Yu ZY., Lu K., Cheng ZF. Analysis of the correlation between HP infection and blood homocysteine levels and CSX. // Zhejiang Clinical Medicine Journal. 2018 .20.-P 1012–3.
2. Huang M., Zhu L., Yao Y. 2021. Association between Helicobacter pylori infection and systemic arterial hypertension: a meta-analysis // Journal Arquivos Brasileiros de Cardiologia 2021.117(2). -P 626–636.
3. Kowalski M. 2001. Helicobacter pylori (H. pylori) infection in coronary artery disease: inflfluence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specifific DNA in human coronary atherosclerotic plaque. //Journal of Physiology and Pharmacology -2001.52. -P 3–31.
4. Agita A., Alsagaff MT. Inflammation, Immunity, and Hypertension. // Acta medica Indonesiana - 2017.49 (2). -P 158–165.
5. Jeong HY., Park KM., Lee MJ., Yang DH., Lee SY. Vitamin D and Hypertension. // Electrolyte & blood pressure: E& BP-2017. 15(1)- P1–11.
6. Shafrir A., Shauly-Aharonov M., Katz LH., Ackerman Z. The Association between Serum Vitamin D Levels and Helicobacter pylori. // Presence and Eradication- 2021.13(1)-P 13-28.
7. Tousoulis D., Davies GJ., Asimakopoulos G., Homaei H, Zouridakis., Kaski JC. Vascular cell adhesion molecule-1 and inter cellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). // Clinical Cardiology- 2001. 24.-P 301-304
8. Patel., Ali M.K., Cardiovascular mortality associated with 5 leading risk factors: National and state preventable fractions estimated from survey data. // Annals of Internal Medicine - 2015. 163.-P 245–253.
9. Dore., Pes G.M. The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease. // Journal of Atherosclerosi and Thrombosis.- 2021. 28.-P 604–610.
10. Szwed P., Gasecka A.,Filipiak, K.J. Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications. // Journal of Clinical and Medicine.-2021. 10.-P 25-39.
11. Kalisperati P., Spanou E., Pateras IS., et al. Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis. // Frontiers in genetics.- 2017. 8.-P 20.
12. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood coagulation & fibrinolysi. // An international journal in haemostasis and thrombosis. -1999. 10.1.-P 9–12.
13. Kowalski M., Pawlik M., Konturek JW., Konturek SJ. Helicobacter infection in coronary artery disease. // Journal of Physiology and Pharmacology.- 2006.3. -P 101–11.
14. Lee SY., Kim DK., Son HJ., Lee JH., Kim YH., Kim JJ., et al. The impact of Helicobacter pylori infection on coronary heart disease in Korean Population. // Korean Journal of Gastroenterology. 2004.44. -P 193–823.
15. Franceschi F., Niccoli G., Ferrente G., Gasbarrini A., Baldi A., Candelli M, et al., Cag A. antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and meta-analysis of 4241 cases. // Atherosclerosis. 2009.202.-P 535–42.
16. Migneco A., Ojetti V., Specchia L., Franceschi F., Candelli M., Mettimano M, et al. Eradication of Helico bacter pylori infection improves blood pressure values in patients affected by hypertension. // Helicobacter. 2003. 8(6).-P 585–589.
17. Yamaoka Y., Kita M, Kodama T., Sawai N., Imanishi J. Helicobacter pylori CagA gene and expression of cytokine messenger RNA in gastric mucosa. // Gastroenterology. 1996. 110(6).-P 1744–1752.
18. Longo-Mbenza B., Nsenga JN., Mokondjimobe E., Gombet T., Assori IN., Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. // Vascular health and risk management. 2012. 6: -P 455–461.
19. Ping Yang ., Wei Shi. Helicobacter pylori and hypertension: a cross-sectional study based on a healthy population. // Research Square Platform LLC. 10.21203.
20. Franceschi F., Annalisa T., Teresa DR., Giovanna D., Ianiro G., Franco S, et al. Role of Helicobacter pylori infection on nutrition and metabolism. // World journal of gastroenterology: WJG. 2014. 20(36): -P 12809 – 12817.
21. Xiong XL, Chen J, He MA, Wu TC, Yang HD. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: The Dongfeng-Tongji cohort. Journal of Clinical Hypertension. 2020; 22(8).-P 234-300.
22. Liuba P., Pesonen E., Paakkari I., Batra S., Andersen L., Forslid A., et al. Co-infection with Chlamydia pneumoniae and Helicobacter pyloriresults in vascular endothelial dysfunction and enhanced VCAM-1 expression in ApoE-knockout mice. J Vasc Res. (2003) 40:115–
23. Yu ZY., Lu K., Cheng ZF. Analysis of the correlation between HP infection and blood homocysteine levels and CSX. // Zhejiang Clinical Medicine Journal. 2018 .20.-P 1012–3.
Published
2023-12-06
How to Cite
Набижонова, Б. Д. (2023). Патогенетический Анализ Взаимосвязи Между Helicobacter Pylori И Артериальной Гипертензией. Central Asian Journal of Medical and Natural Science, 4(6), 911-915. Retrieved from https://www.cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/2150
Section
Articles
